Login to Your Account

Clinic Roundup

Wednesday, March 27, 2013
• Gentium SpA, of Villa Guardia, Italy, said a medical team from the National University Corporation Hamamatsu University School of Medicine, Fukushima Medical University, administered defibrotide to the first subject in a Phase I study.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription